Do v. Singh et al - Stockholders Suit
Summary
The U.S. District Court for the Northern District of California has filed a new civil case, Do v. Singh et al. The case, initiated on March 26, 2026, involves a Verified Shareholder Derivative Complaint against Vistagen Therapeutics, Inc. and its directors.
What changed
A new civil case, Do v. Singh et al (Case Number: 3:26-cv-02656), has been filed in the U.S. District Court for the Northern District of California. The filing includes a Verified Shareholder Derivative Complaint against Ann M. Cunningham, Joanne Curley, Paul Edick, Margaret M. Fitzpatrick, Jerry B. Gin, Joshua Prince, Mary L. Rotunno, Jon S. Saxe, Shawn K. Singh, and Vistagen Therapeutics, Inc. The basis of the suit is Federal Question, with the Nature of Suit identified as Stockholders Suits.
This filing initiates legal proceedings that could impact corporate governance and shareholder rights at Vistagen Therapeutics, Inc. Compliance officers and legal professionals should monitor this case for potential implications related to director liability, shareholder derivative actions, and securities law compliance. No specific compliance deadlines or penalties are detailed in this initial filing, but the nature of the suit suggests potential for significant legal scrutiny and possible remedies if the allegations are proven.
What to do next
- Review the Verified Shareholder Derivative Complaint filed in Do v. Singh et al.
- Assess potential impact on Vistagen Therapeutics, Inc. and its directors.
- Monitor case developments for any new obligations or legal precedents.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Do v. Singh et al
Case Number: 3:26-cv-02656 Location: San Francisco Case Type: Civil Case Basis: Federal Question Nature of Suit: Stockholders Suits Date Filed:
March 26, 2026
Last Filing Date:
March 26, 2026
View Publicly Available Documents Case Summary No summary of this case is available
Recent Filings
| Date Filed | Docket Number | Document Description |
|---|---|---|
| 03-26-26 | 1 | COMPLAINT - Verified Shareholder Derivative Complaint against Ann M. Cunningham, Joanne Curley, Paul Edick, Margaret M. Fitzpatrick, Jerry B. Gin, Joshua Prince, Mary L. Rotunno, Jon S. Saxe, Shawn K. Singh, Vistagen Therapeutics, Inc. ( Fili |
| 03-26-26 | 2 | Proposed Summons. (Manifold, Betsy) |
| 03-26-26 | 3 | Certificate of Interested Entities by Danny Do (Manifold, Betsy) |
Named provisions
Related changes
Get daily alerts for NDCA Recently Filed Documents
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from N.D. California.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when NDCA Recently Filed Documents publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.